Diana Röttger, PhD, is a seasoned professional in the healthcare and technology sectors, currently serving as Principal at APEX Ventures, where the focus is on investing in deep-tech medical companies across Europe. Röttger holds multiple board positions, including Board Member at CardiaTec Biosciences and Robeauté, and serves as a Board Observer at Quibim. Additionally, Röttger is an Executive Advisor at Mindpeak GmbH and contextflow, and a Council Member at GLG, contributing expertise in AI, cloud technology, and health tech. Previously, Röttger was the Chief Scientific Alliance Officer at IAG, where engagement with biotech clients centered on advancing AI and imaging technologies in clinical trials. Röttger's academic background includes a degree in Computational Visualistics from the University of Koblenz-Landau and a smaller thesis in Medical Informatics from LUT University.